Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: Findings from a prospective population-based study

International Journal of Geriatric Psychiatry

Volumn 21, Issue 7, 2006, Pages 661-673

  Ball, Sarah L ^a   Holland, Anthony J ^a   Hon, Johnny ^a   Huppert, Felicia A ^a   Treppner, Peter ^a   Watson, Peter C ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

Author keywords

Alzheimer's disease; Behaviour; Dementia; Down's syndrome; Frontal lobe; Personality; Prospective study

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; BRAIN DYSFUNCTION; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DOWN SYNDROME; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; HYPOTHESIS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PERSONALITY DISORDER; POPULATION RESEARCH; PROSPECTIVE STUDY; SAMPLE (STATISTICS); STAGING;

ADULT; AGED; ALZHEIMER DISEASE; DOWN SYNDROME; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; PERSONALITY DISORDERS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PSYCHOMOTOR AGITATION; TIME FACTORS;

EID: 33746406026     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1545     Document Type: Article

References (63)

1. Allsop D, Kidd M, Landon M, Tomlinson A. 1986. Isolated senile plaque cores in Alzheimer's disease and Down's syndrome show differences in morphology. J Neurol Neurosurg Psychiatry 49: 886-892.
2. American Psychiatric Association. 1994, Diagnostic and Statistical Manual of Mental Disorder (4th edn). American Psychiatric Association: Washington, DC.
3. Aylward EH, Li Q, Honeycutt NA, et al. 1999. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am J Psychiatry 156: 564-568.
4. Azizeh BY, Head E, Ibrahim MA, et al. 2000. Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs. Exp Neurol 163: 111-122.
5. Ball SL, Holland AJ, Huppert FA, Treppner P, Dodd K. The CAMDEX-DS: The Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities. Cambridge University Press: Cambridge.
6. Ball SL, Holland AJ, Huppert FA, Treppner P, Watson P, Hon J. 2004. The Modified CAMDEX Informant Interview is a Valid and Reliable Tool for Use in the Diagnosis of Dementia in Adults with Down's Syndrome. J Intellect Disabil Res 48: 611-620.
7. Cooper SA, Prasher VP. 1998. Maladaptive behaviours and symptoms of dementia in adults with Down's syndrome compared with adults with intellectual disability of other aetiologies. J Intellect Disabil Res 42: 293-300.
8. Crayton L, Oliver C, Holland AJ, Bradbury J, Hall S. 1998. The neuropsychological assessment of age related cognitive deficits in adults with Down's Syndrome. J Appl Res in Intellect Disabil 11: 255-272.
9. Crome L, Stern L. 1972. Pathology of Mental Retardation. Williams and Wilkins: Baltimore, MD.
10. Cummings JL, Victoroff JI. 1990. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 3: 140-158.
11. Dalton AJ, Crapper DR, Schlotterer GR. 1974. Alzheimer's disease in Down's syndrome: visual retention deficits. Cortex 10: 366-377.
12. Dalton AJ, Fedor BL. 1998. Onset of dyspraxia in aging persons with Down syndrome: longitudinal studies. J Intellect Development Disabil 23: 13-24.
13. Dalton AJ, Mehta PD, Fedor BL, Patti PJ. 1999. Cognitive changes in memory precede those in praxis in aging persons with Down Syndrome. J Intellect Development Disabil 24: 169-187.
14. Das JP, Mishra RK. 1995. Assessment of cognitive decline associated with aging: a comparison of individuals with Down's syndrome and other etiologies. Res Dev Disabil 16: 11-25.
15. Devenny DA, Krinsky McHale SJ, Sersen G, Silverman WP. 2000. Sequence of cognitive decline in dementia in adults with Down's syndrome. J Intellect Disabil Res 44: 654-665.
16. de la Monte SM, Hedley-Whyte ET. 1990. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease. J Neuropathol Exp Neurol 49: 509-520.
17. Donaldson C, Tarrier N, Burns A. 1997. The impact of the symptoms of dementia on caregivers. Br J Psychiatry 170: 62-68.
18. Donaldson S. 2002. Work stress and people with Down syndrome and dementia. Downs Syndr Res Pract 8: 74-78.
19. Godridge H, Reynolds GP, Czudek C, Calcutt NA, Benton M. 1987. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. J Neurol Neurosurg Psychiatry 50: 775-778.
20. Gregory CA, Hodges JR. 1993. Dementia of frontal type and the focal lobar atrophies. Int Rev Psychiatry 5: 397-406.
21. Haxby JV. 1989. Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults. J Ment Defic Res 33: 193-210.
22. Head E, Lott IT. 2004. Down syndrome and beta-amyloid deposition. Curr Opin Neurol 17: 95-100.
23. Hewitt KE, Carter G, Jancar J. 1985. Ageing in Down's syndrome. Br J Psychiatry 147: 58-62.
24. Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH. 1995. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol 52: 379-391.
25. Holland AJ, Hon J, Huppert FA, Stevens F. 2000. Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. J Intellect Disabil Res 44: 138-146.
26. Holland AJ, Hon J, Huppert FA, Stevens F, Watson P. 1998. Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome. Br J Psychiatry 172: 493-498.
27. Hollander M, Wolfe DA. 1973. Nonparametric Statistical Methods. Wiley: New York.
28. Hon J, Huppert FA, Holland AJ, Watson P. 1999. Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG). Br J Clin Psychol 38: 155-165.
29. Huppert FA, Brayne C, O'Connor DW. 1994. Dementia and Normal Aging. Cambridge University Press: Cambridge.
30. Huppert FA, Jorm AF, Brayne C, Girling DM. 1996. Psychometric properties of the CAMCOG and its efficacy in the diagnosis of dementia. Aging Neuropsychol Cogn 3: 201-214.
31. Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL. 2004. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord 18: 17-21.
32. Krasuski JS, Alexander GE, Horwitz B, Rapoport SI, Schapiro MB. 2002. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am J Psychiatry 159: 74-81.
33. Lai F, Williams RS. 1989. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46: 849-853.
34. Mann DM. 1988. The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43: 99-136.
35. Mann DM, Royston MC, Ravindra CR. 1990. Some morphometric observations on the brains of patients with Down's syndrome: their relationship to age and dementia. J Neurol Sci 99: 153-164.
36. Mann DM, Yates PO, Marcyniuk B, Ravindra CR. 1985. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. J Ment Defic Res 29: 125-135.
37. Mann DM, Yates PO, Marcyniuk B, Ravindra CR. 1986. The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol 12: 447-457.
38. Mortimer JA. 1988. Do psychosocial risk factors contribute to Alzheimer's disease? In Etiology of Dementia of Alzheimer's Type, Henderson AS, Henderson JH (eds). John Wiley & Sons Ltd: Chichester; 39-52.
39. Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik C. 1994. Distribution of Tau Protein in Down's Syndrome: quantitative Differences from Alzheimer's disease. Developmental Brain Dysfunct 7: 311-329.
40. Nelson L, Johnson JK, Freedman M, et al. 2005. Learning and memory as a function of age in Down syndrome: a study using animal-based tasks. Prog Neuropsychopharmacol Biol Psychiatry 29: 443-453.
41. Nelson LD, Orme D, Osann K, Lott IT. 2001. Neurological changes and emotional functioning in adults with Down Syndrome. J Intellect Disabil Res 45: 450-456.
42. Norton LE, Malloy PF, Salloway S. 2001. The impact of behavioral symptoms on activities of daily living in patients with dementia. Am J Geriatr Psychiatry 9: 41-48.
43. Oliver C, Crayton L, Holland A, Hall S, Bradbury J. 1998. A four year prospective study of age-related cognitive change in adults with Down's syndrome. Psychol Med 28: 1365-1377.
44. Petersen RC, Smith GE, Ivnik RJ, Kokmen E. 1994. Memory function in very early Alzheimer's disease. Neurology 44: 867-872.
45. Petersen RC. 2000. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia 15: 93-101.
46. Prasher VP. 2004. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. Int J Geriatr Psychiatry 19: 509-515.
47. Prasher VP, Adams C, Holder R, The Downs Syndrome Research Group. 2003. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study. Int J Geriatr Psychiatry 18: 549-551.
48. Prasher VP, Huxley A, Haque MS, Down syndrome Ageing Study. 2002. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease-Pilot study. Int J Geriatr Psychiatry 17: 270-278.
49. Roth M, Huppert F, Tym E, Mountjoy C. 1988. CAMDEX: the Cambridge Examination for Mental Disorder of the Elderly. Cambridge University Press: Cambridge.
50. Roth M, Huppert FA, Mountjoy CQ, Tym E. 1998. CAMDEX-R: The Cambridge Examination for Mental Disorders of the Elderly (Revised). Cambridge University Press: Cambridge.
51. Royall DR, Cordes JA, Polk M. 1998. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 64: 588-594.
52. Schapiro MB, Haxby JV, Grady CL. 1992. Nature of mental retardation and dementia in Down syndrome: study with PET, CT, and neuropsychology. Neurobiol Aging 13: 723-734.
53. Schapiro MB, Luxenberg JS, Kaye JA, Haxby JV, Friedland RP, Rapoport SI. 1989. Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages. Neurology 39: 1349-1353.
54. Small BJ, Mobly JL, Laukka EJ, Jones S, Backman L. 2003. Cognitive deficits in preclinical Alzheimer's disease. Acta Neurol Scand Suppl 179: 29-33.
55. Thase ME, Liss L, Smeltzer D, Maloon J. 1982. Clinical evaluation of dementia in Down's syndrome: a preliminary report. J Ment Defic Res 26: 239-244.
56. Thase ME, Tigner R, Smeltzer DJ, Liss L. 1984. Age-related neuropsychological deficits in Down's syndrome. Biol Psychiatry 19: 571-585.
57. Winblad B, Jelic V. 2004. Long-Term Treatment of Alzheimer Disease: efficacy and Safety of Acetylcholinesterase Inhibitors. Alzheimer Dis Assoc Disord 18: S2-S8.
58. Wisniewski K, Howe J, Williams DG, Wisniewski HM. 1978. Precocious aging and dementia in patients with Down's syndrome. Biol Psychiatry 13: 619-627.
59. Wisniewski KE, Wisniewski HM, Wen GY. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17: 278-282.
60. World Health Organisation. 1992. ICD-10 International Statistical Classification of Diseases and Related Health Problems, 10th edn. WHO: Geneva.
61. Yates CM, Simpson J, Maloney AF, Gordon A, Reid AH. 1980. Alzheimer-like cholinergic deficiency in Down syndrome [letter]. Lancet 2: 979.
62. Young EC, Kramer BM. 1991. Characteristics of age-related language decline in adults with Down syndrome. Ment Retard 29: 75-79.
63. Zigman WB, Schupf N, Lubin RA, Silverman WP. 1987. Premature regression of adults with Down syndrome. Am J Ment Defic 92: 161-168.